K. Havemann

6.9k total citations
267 papers, 5.2k citations indexed

About

K. Havemann is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, K. Havemann has authored 267 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Oncology, 67 papers in Molecular Biology and 59 papers in Epidemiology. Recurrent topics in K. Havemann's work include Lung Cancer Research Studies (54 papers), Neuroendocrine Tumor Research Advances (43 papers) and Peptidase Inhibition and Analysis (25 papers). K. Havemann is often cited by papers focused on Lung Cancer Research Studies (54 papers), Neuroendocrine Tumor Research Advances (43 papers) and Peptidase Inhibition and Analysis (25 papers). K. Havemann collaborates with scholars based in Germany, United States and Denmark. K. Havemann's co-authors include W Schmidt, R. Egbring, C. Gropp, Gabriele Jaques, Gerold Bepler, M. Gramse, Ulrich Kaiser, Martin Rotsch, M. Wolf and G. Fuchs and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

K. Havemann

258 papers receiving 4.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
K. Havemann 1.9k 1.8k 1.1k 917 716 267 5.2k
Shosaku� Nomura 2.0k 1.1× 1.1k 0.6× 941 0.8× 745 0.8× 503 0.7× 310 6.5k
José Vassallo 1.1k 0.6× 1.2k 0.6× 499 0.4× 471 0.5× 435 0.6× 211 3.8k
Masayuki Iwano 3.4k 1.8× 1.2k 0.7× 1.4k 1.2× 420 0.5× 998 1.4× 138 8.4k
Elena Ranieri 1.9k 1.0× 1.6k 0.8× 918 0.8× 476 0.5× 620 0.9× 148 5.7k
Juri Kopolovic 1.6k 0.9× 672 0.4× 456 0.4× 467 0.5× 513 0.7× 137 5.5k
David K. Madtes 1.1k 0.6× 1.0k 0.6× 1.9k 1.6× 530 0.6× 372 0.5× 73 4.9k
Frank Strutz 3.2k 1.7× 1.1k 0.6× 1.5k 1.4× 369 0.4× 452 0.6× 97 7.8k
Penelope Korkolopoulou 1.9k 1.0× 1.2k 0.6× 612 0.5× 372 0.4× 779 1.1× 208 4.6k
H.R. Lijnen 1.5k 0.8× 604 0.3× 1.2k 1.0× 885 1.0× 2.7k 3.8× 147 5.5k
Yoshihisa Nojima 2.2k 1.2× 844 0.5× 514 0.5× 312 0.3× 362 0.5× 231 6.1k

Countries citing papers authored by K. Havemann

Since Specialization
Citations

This map shows the geographic impact of K. Havemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Havemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Havemann more than expected).

Fields of papers citing papers by K. Havemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Havemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Havemann. The network helps show where K. Havemann may publish in the future.

Co-authorship network of co-authors of K. Havemann

This figure shows the co-authorship network connecting the top 25 collaborators of K. Havemann. A scholar is included among the top collaborators of K. Havemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Havemann. K. Havemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaiser, Ulrich, et al.. (1996). Soluble CD56 (NCAM): a new differential-diagnostic and prognostic marker in multiple myeloma. Annals of Hematology. 73(3). 121–126. 15 indexed citations
2.
Weide, Rudolf, et al.. (1995). The Role of Decreased Retinoblastoma Protein Expression in Acute Myelomonocytic and Monoblastic Leukemias. Leukemia & lymphoma. 17(1-2). 135–137. 2 indexed citations
3.
Heymanns, Jochen, et al.. (1993). Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types. European Journal of Cancer. 29(16). 2250–2255. 24 indexed citations
4.
Klausmann, Martine, et al.. (1989). Granulocyte-macrophage colony-stimulating factor binding sites and oxidative metabolism in human granulocytes. Annals of Hematology. 59(6). 486–492. 2 indexed citations
5.
Kolb, Gerald, W. Fischer, Thomas Müller, et al.. (1989). Granulocyte-related bioincompatibility of hemodialysis: inhibition of oxidative metabolism, degranulation reaction, enzyme release and leukocyte sequestration in the lung. The International Journal of Artificial Organs. 12(5). 294–298. 6 indexed citations
6.
Havemann, K., et al.. (1988). Oncogene expression in the spectrum of pulmonary carcinoma. Lung Cancer. 4(3-4). 155–161. 4 indexed citations
8.
Köppler, H., Karl-Heinz Pflüger, R. Pfab, et al.. (1987). Multizentrische Studie zur Behandlung hochmaligner Non-Hodgkin-Lymphome mit Polychemotherapie (CHOPV) und Bestrahlung. Oncology Research and Treatment. 10(1). 34–40.
9.
Havemann, K., M. Wolf, Rolf Holle, et al.. (1987). Alternating versus sequential chemotherapy in small cell lung cancer. A randomized german multicenter trial. Cancer. 59(6). 1072–1082. 46 indexed citations
11.
Havemann, K. & C. Gropp. (1979). Biological and immunological aspects of small cell carcinoma of the lung in relation to ectopic hormone production.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(4). 186–94. 5 indexed citations
12.
Schmidt, Helmut H., et al.. (1979). Zirkulierende Immunkomplexe bei Patienten mit malignen Lymphomen. Annals of Hematology. 38(6). 435–446. 8 indexed citations
13.
Havemann, K., et al.. (1978). Effect of neutral proteases from human granulocytes on colony forming cells in vitro. Annals of Hematology. 36(2). 73–80. 1 indexed citations
14.
Fuchs, G., R. Egbring, & K. Havemann. (1977). Fibrinogen marburg a new genetic variant of fibrinogen. Annals of Hematology. 34(2). 107–118. 24 indexed citations
15.
Solomon, Alan, W Schmidt, & K. Havemann. (1976). Bence Jones proteins and light chains of immunoglobulins. XIII. Effect of elastase-like and chymotrypsin-like neutral proteases derived from human granulocytes on Bence Jones proteins.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 117(3). 1010–4. 24 indexed citations
16.
Egbring, R., et al.. (1976). Erfahrungen bei der Langzeitbehandlung des angeborenen Faktor XIII-Mangels mit Faktor XIII-Konzentrat. Annals of Hematology. 33(6). 367–375. 3 indexed citations
17.
Schmidt, W, R. Egbring, & K. Havemann. (1975). Effect of elastase-like and chymotrypsin-like neutral proteases from human granulocytes on isolated clotting factors. Thrombosis Research. 6(4). 315–326. 95 indexed citations
18.
Havemann, K., et al.. (1974). Optimal Labelling Conditions for Thymidine Incorporation in PHA- and PPD-Stimulated Human Lymphocytes – Effect of Adherent Cells. International Archives of Allergy and Immunology. 46(5). 647–654. 2 indexed citations
19.
Havemann, K., et al.. (1973). Klinische und erythrokinetische Befunde bei isolierter Aplasie der Erythropoese vor und nach erfolgreicher Therapie mit Kortikosteroiden. Annals of Hematology. 26(3). 193–203. 1 indexed citations
20.
Egbring, R., W Schmidt, & K. Havemann. (1973). Die vereinfachte radiologische Faktor-XIII-Bestimmung und ihre klinische Anwendung bei kongenitalem Faktor-XIII-Mangel (I). Annals of Hematology. 27(1). 6–19. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026